Oxidative Stress and Inflammatory Biomarkers in People with Methamphetamine Use Disorder

키워드

참고문헌 (61)

1. Ramirez SH, "Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells", J Cereb Blood Flow Metab, 29, pp.1933~1945 (2009)
2. Prakash MD, "Methamphetamine : Effects on the brain, gut and immune system", Pharmacol Res, 120, pp.60~67 (2017)
3. Callaghan RC, "Increased risk of Parkinson’s disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs", Drug Alcohol Depend, 120, pp.35~40 (2012)
4. Thomas E, "Methamphetamine-induced psychosis : Clinical features, treatment modalities and outcomes", S Afr J Psychiatr, 22, pp.980~ (2016)
5. Shen H, "A stress steroid triggers anxiety via increased expression of α4βδ GABAA receptors in methamphetamine dependence", Neuroscience, 254, pp.452~475 (2013)
6. Shrestha P, "Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies", Biomed Pharmacother, 154, pp.113591~ (2022)
7. Smith JA, "Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases", Brain Res Bull, 87, pp.10~20 (2012)
8. Ambrogini P, "Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration : The role of vitamin E", Biochim Biophys Acta Mol Basis Dis, 1865, pp.1098~1112 (2019)
9. Chamorro Á, "Neuroprotection in acute stroke : Targeting excitotoxicity, oxidative and nitrosative stress, and inflammation", Lancet Neurol, 15, pp.869~881 (2016)
10. Ito K, "Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine", Psychopharmacology(Berl), 187, pp.293~302 (2006)
11. Flora G, "Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain", Exp Neurol, 179, pp.60~70 (2003)
12. Solhi H, "Oxidative stress and lipid peroxidation in prolonged users of methamphetamine", Drug Metab Lett, 7, pp.79~82 (2014)
13. Ramkissoon A, "Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2", Free Radic Biol Med, 89, pp.358~368 (2015)
14. Kousik SM, "The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation", Front Pharmacol, 3, pp.121~ (2012)
15. Erel O, "A novel and automated assay for thiol", disulphide homeostasis, 2014, pp.47, 326~332
16. Erenler AK, "Clinical utility of thiol", disulfide homeostasis, 2017, pp.63, 867~870
17. Oliveira PVS, "Implications of plasma thiol redox in disease", Clin Sci(Lond), 132, pp.1257~1280 (2018)
18. Circu ML, "Reactive oxygen species, cellular redox systems, and apoptosis", Free Radic Biol Med, 48, pp.749~762 (2010)
19. Watanabe H, "Clinical implications associated with the posttranslational modificationinduced functional impairment of albumin in oxidative stressrelated diseases", J Pharm Sci, 106, pp.2195~2203 (2017)
20. Yang C, "Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke", Am J Physiol Cell Physiol, 316, pp.C135~ (2019)
21. Tampa M, "Ischemia-modified albumin-a potential new marker of oxidative stress in dermatological diseases", Medicina(Kaunas), 58, pp.669~ (2022)
22. Bar-Or D, "A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report", J Emerg Med, 19, pp.311~315 (2000)
23. Zurawska-Płaksej E, "Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome", J Endocrinol Invest, 37, pp.819~827 (2014)
24. Sbarouni E, "Ischemia modified albumin changes-review and clinical implications", Clin Chem Lab Med, 49, pp.177~184 (2011)
25. Tanaka T, "IL-6 in inflammation, immunity, and disease", Cold Spring Harb Perspect Biol, 6, pp.a016295~ (2014)
26. Hacimusalar Y, "Methamphetamine’s effects on oxidative stress markers may continue after detoxification : A case–control study", Psychiatry Clin Psychopharmacol, 29, pp.361~367 (2019)
27. Kotan VO, "Thiol", disulphide homeostasis in men with heroin addiction, 2017, pp.30, 95~100
28. Guler EM, "Investigation of DNA damage, oxidative stress, and inflammation in synthetic cannabinoid users", Hum Exp Toxicol, 39, pp.1454~1462 (2020)
29. Huseyin Bayazit, "Evaluation of Oxidant", Antioxidant Status and Cytokine Levels in Patients with Cannabis Use Disorder, 2017, pp.15(3), 237~242[DOI]
30. Tocharus J, "Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines", J Pineal Res, 48, pp.347~352 (2010)
31. Shafahi M, "Crocin inhibits apoptosis and astrogliosis of hippocampus neurons against methamphetamine neurotoxicity via antioxidant and anti-inflammatory mechanisms", Neurochem Res, 43, pp.2252~2259 (2018)
32. Asanuma M, "Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug", Neurosci Lett, 352, pp.13~16 (2003)
33. Beirami E, "Intranasal insulin treatment alleviates methamphetamine induced anxiety-like behavior and neuroinflammation", Neurosci Lett, 660, pp.122~129 (2017)
34. Wan F, "Ginkgolide B suppresses methamphetamine-induced microglial activation through TLR4-NF-κB signaling pathway in BV2 cells", Neurochem Res, 42, pp.2881~2891 (2017)
35. Li MJ, "Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder", Drug Alcohol Depend, 206, pp.107776~ (2020)
36. McKetin R, "N-acetylcysteine(NAC)for methamphetamine dependence : A randomised controlled trial", EClinicalMedicine, 38, pp.101005~ (2021)
37. Sharma HS, "Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat : An experimental study using light and electron microscopy", J Chem Neuroanat, 37, pp.18~32 (2009)
38. Sekine Y, "Methamphetamine causes microglial activation in the brains of human abusers", J Neurosci, 28, pp.5756~5761 (2008)
39. Bilgi M, "Evaluation of the relationship between microalbuminuria and urine ischemia-modified albumin levels in patients with diabetic nephropathy", J Clin Lab Anal, 31, pp.e22058~ (2017)
40. Abboud H, "Ischemia-modified albumin in acute stroke", Cerebrovasc Dis, 23, pp.216~220 (2007)
41. Bhakthavatsala Reddy C, "Role of"ischemia modified albumin"(IMA)in acute coronary syndromes", Indian Heart J, 66, pp.656~662 (2014)
42. Piwowar A, "Ischemia-modified albumin level in type 2 diabetes mellitus-preliminary report", Dis Markers, 24, pp.311~317 (2008)
43. Kohno M, "The relationship between interleukin-6 and functional connectivity in methamphetamine users", Neurosci Lett, 677, pp.49~54 (2018)
44. Luo Y, "Elevated serum levels of TNF-α, IL-6, and IL-18 in chronic methamphetamine users", Hum Psychopharmacol, 37, pp.e2810~ (2022)
45. Huckans M, "Plasma inflammatory factors are associated with anxiety, depression, and cognitive problems in adults with and without methamphetamine dependence : An exploratory protein array study", Front Psychiatry, 6, pp.178~ (2015)
46. Jaehwa Lim, "White Matter Alterations Associated with Pro-inflammatory Cytokines in Patients with Major Depressive Disorder", Clinical Psychopharmacology and Neuroscience, 19(3), pp.449~458 (2021), 대한정신약물학회[DOI]
47. Wang B, "Methamphetamine modulates the production of interleukin-6 and tumor necrosis factor-alpha via the cAMP", PKA, Int Immunopharmacol, pp.2018, 56[DOI]
48. Yang X, "The relationship between serum cytokine levels and the degree of psychosis and cognitive impairment in patients with methamphetamine-associated psychosis in Chinese patients", Front Psychiatry, 11, pp.594766~ (2020)
49. Wang J, "Peripheral inflammatory biomarkers of methamphetamine withdrawal patients based on the neuro-inflammation hypothesis : The possible improvement effect of exercise", Front Psychiatry, 12, pp.795073~ (2021)
50. Volkow ND, "Low level of brain dopamine D2 receptors in methamphetamine abusers : Association with metabolism in the orbitofrontal cortex", Am J Psychiatry, 158, pp.2015~2021 (2001)
51. Papageorgiou M, "Methamphetamine and its immune-modulating effects", Maturitas, 121, pp.13~21 (2019)
52. Banks WA, "Passage of cytokines across the blood-brain barrier", Neuroimmunomodulation, 2, pp.241~248 (1995)
53. Gao Q, "Sepsis-associated encephalopathy and blood-brain barrier dysfunction", Inflammation, 44, pp.2143~2150 (2021)
54. Tosun M, "Handbook of nutrition, diet, and the eye", pp.87~96 (2014), Academic Press
55. Arslan B, "Evaluation of thiol homeostasis in multiple sclerosis and neuromyelitis optica spectrum disorders", Front Neurol, 12, pp.716195~ (2021)
56. Zahorec R, "Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill", Bratisl Lek Listy, 102, pp.5~14 (2001)
57. Heather E. Soder, "Elevated Neutrophil to Lymphocyte Ratio in Older Adults with Cocaine Use Disorder as a Marker of Chronic Inflammation", Clinical Psychopharmacology and Neuroscience, 18(1), pp.32~40 (2020), 대한정신약물학회[DOI]
58. Orum MH, "Complete blood count alterations due to the opioid use : What about the lymphocyte-related ratios, especially in monocyte to lymphocyte ratio and platelet to lymphocyte ratio?", J Immunoassay Immunochem, 39, pp.365~376 (2018)
59. Guzel D, "Alterations of the hematologic cells in synthetic cannabinoid users", J Clin Lab Anal, 31, pp.e22131~ (2017)
60. Serdar Karatoprak, "Neutrophil-lymphocyte and Platelet-lymphocyte Ratios among Adolescents with Substance Use Disorder: A Preliminary Study", Clinical Psychopharmacology and Neuroscience, 19(4), pp.669~676 (2021), 대한정신약물학회[DOI]
61. Demir B, "Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in methamphetamine use disorder", Psychiatry Clin Psychopharmacol, 31, pp.34~39 (2021)

관련 논문AI추천